General and History

• Altman, Lawrence K., "Dr. Louis S. Goodman, 94, Chemotherapy Pioneer, Dies", New York Times, November 28, 2000 (sec. A, p. 27).

• Brouwer, C.A.J., Gietema, J.A., van den Berg, M.P., Bink-Boelkens, M.T.E., Elzenga, N.G., Haaksma, J., Kamps, W.A., Vonk, J.M., de Vries, E.G.E., and Postma, A.  "Long-term cardiac follow-up in survivors of a malignant bone tumour." Annals of Oncology Advanced Access (online resource; July 20, 2006), available at: http://annonc.oxfordjournals.org/cgi/reprint/mdl156v1.

• Celgene Biopharmaceutical press release (March 25, 2008): http://ir.celgene.com/phoenix.zhtml?c=111960&p=irol-newsArticle&ID=1121403&highlight

• Goodman, Jordan and Vivien Walsh. The Story of Taxol: Nature and Politics in the Pursuit of an Anti-Cancer Drug. Cambridge: Cambridge University Press, 2001.

• Minotti G, Cairo G, Monti E. "Role of iron in anthracycline cardiotoxicity: new tunes for an old song?" FASEB J, 13 (1999).

• Patt, D. A.,  Duan, Z.,  Hortobagyi, G., Giordano, S. H. "Acute Myeloid Leukemia (AML) in older women after adjuvant breast cancer therapy."  J. Clinical Oncology, 4: 18S (June 20 Supp.) 1006: 560.

• Pratt, William B. The Anticancer Drugs, 2ed. New York: Oxford Univ. Press USA, 1994.

• Rivera E., "Current Status of Liposomal Anthracycline Therapy in Metastatic Breast Cancer." Clin. Breast Cancer 2003, 4: Supp 2, S76-S83.  Full text available online at: http://cigjournals.metapress.com/content/j2r0220327577p70/

• Robson, D.,  Verma, S.  "Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?" The Oncologist, Oct. 2009 14:10, 950-958.

• Slamon, D., Leyland-Jones, B., Shak, S. et al. "Addition of Herceptin to first-line chemotherapy for Her2 overexpressing metastatic breast cancer markedly increases anticancer activity: a randomized, multinational controlled phase III trial." Proc Am Soc Clin Oncol. 1998; 17.

• Tan, C., Tasaka, H., Kou-Ping, Y., et al. "Daunomycin, An Antitumor Antibiotic, In the Treatment of Neoplastic Disease. Clinical Evaluation with Special Reference to Childhood Leukemia." Cancer 20(3) (1967).
  

Mechanism of Action

• Ashley, N., Poulton, J. "Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs." Biochem. and Biophys. Res.Comm., 378 (January 16, 2009).
  

Specific Drug References

• Aclarubicin: NCIThesaurus:  http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C202

• Amrubicin: NCIThesaurus:  http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C80089

• Cyclophosphamide: Medline Plus (U.S. Nat'l Library of Medicine and Nat'l Institutes of Health joint resources): http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682080.html

• DaunoXome: NCIThesaurus: http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1340; 

• DaunoXome FDA drug summary: http://www.drugs.com/pro/daunoxome.html

• Doxorubicin: Medline Plus (U.S. Nat'l Library of Medicine and Nat'l Institutes of Health joint resources):  http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682221.html

• Esorubicin:  NCI Thesaurus:  http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C972

• Pirarubicin: NCIThesaurus:  http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1197

• Valrubicin: NCIThesaurus:  http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1340

• Valrubicin: Medpedia: http://wiki.medpedia.com/Valrubicin
  

Leading Causes of Death, U.S. Females, by Age

• U.S. Centers for Disease Control, Leading Causes of Death in Females, 2006 (Age Group chart as downloadable PDF):  http://www.cdc.gov/women/lcod/

• Susan G. Komen for the Cure, Young Breast Cancer Survivors Conference press release, January 10, 2008 (full text available online at: http://ww5.komen.org/KomenNewsArticle.aspx?id=7460&terms=young+breast+cancer+survivors).